FeMOFs and CO Reduce Inflammation in Cardiovascular Stents
Author Information
Author(s): Xie Yinhong, Chi Mengchen, Yang Xinlei, Dong Ruichen, Yang Ao, Yin Antao, Weng Yajun
Primary Institution: Southwest Jiaotong University
Hypothesis
Can the incorporation of FeMOFs and carbon monoxide in PLA stent materials reduce NETosis and macrophage inflammatory response?
Conclusion
The study found that PLA/FeMOFs/CO effectively reduced inflammation and restenosis associated with PLA implantation.
Supporting Evidence
- PLA/FeMOFs/CO significantly inhibited NETs release and neutrophil elastase expression.
- In vivo results confirmed reduced macrophage and neutrophil mediated inflammatory response.
- CO release from PLA/FeMOFs/CO improved endothelial cell activity and reduced platelet activation.
Takeaway
This study shows that adding special materials to heart stents can help reduce inflammation and make them safer for patients.
Methodology
The study involved in vitro and in vivo evaluations of PLA/FeMOFs/CO materials, including cell culture and animal implantation experiments.
Participant Demographics
Male Sprague-Dawley rats and New Zealand White rabbits were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website